Growth factors in progressive renal disease

Nephrology

Volumn 5, Issue 4, 2000, Pages 251-261

  Johnson, David W ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Angiotensin II; Cytokines; Insulin like growth factor I; Kidney failure (chronic); Renal fibrogenesis; Transforming growth factor

Indexed keywords

ANGIOTENSIN; ARGININE; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA; TRAPIDIL;

DRUG ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GLOMERULUS FILTRATION; HUMAN; KIDNEY DISEASE; KIDNEY PARENCHYMA; KIDNEY TUBULE ABSORPTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN RESTRICTION; REVIEW; TISSUE REPAIR;

EID: 0034473330     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1797.2000.00001.x     Document Type: Review

References (71)

1. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides
2. Transforming growth factor-beta and angiotensin II: The missing link from glomerular hyperfiltration to glomerulosclerosis?
3. The emerging role of transforming growth factor-beta in kidney diseases
4. Fibrogenic effects of cyclosporin A on the tubulointerstitium: Role of cytokines and growth factors
5. 1 and PDGF
6. + exchange activity
7. Neutralisation of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice
8. Early molecular mechanisms in the progression of renal failure: Role of growth factors and protooncogenes
9. Low-protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor-beta in experimental glomerular sclerosis
10. Lipids and progressive renal failure
11. Growth hormone, the insulin-like growth factor system and the kidney
12. Insulin-like growth factor-I stimulates apical sodium-hydrogen exchange in human proximal tubule cells
13. Effects of insulin-like growth factor binding proteins on human proximal tubule cells post-nephrectomy
14. Additive increase in kidney insulin-like growth factor I and initial enlargement in uninephrectomised-diabetic rats
15. Diabetic kidney disease: The role of growth factors
16. Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes
17. Platelet derived growth factor receptors in the kidney - Upregulated expression in inflammation
18. Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study
19. Paracrine stimulation of human renal fibroblasts by proximal tubule cells
20. Role of platelet-derived growth factor in renal injury
21. Increased platelet-derived growth factor in the kidneys of cyclosporin-treated rats
22. Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and IL-6 mRNA expression in vitro
23. Cytokines, growth factors and renal injury: Where do we go now?
24. Pharmacokinetics of the PDGF-antagonist trapidil in patients with and without renal impairment
25. In vitro effects of simvastatin on human tubulointerstitial cells and cyclosporin nephrotoxicity
26. Enalaprilat directly ameliorates in vitro cyclosporin nephrotoxicity in human tubulointerstitial cells
27. The intra-renal renin-angiotensin system
28. Renal injury from angiotensin II-mediated hypertension
29. Angiorensin II-mediated renal injury
30. Evidence for the role of angiotensin in the establishment and maintenance of renal morphology
31. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy
32. Randomized, double-blind, placebo-controlled study of arginine supplementation in chronic renal failure
33. High glucose inhibits nitric oxide production in cultured rat mesangial cells
34. Localization and regulation of nitric oxide synthase isoforms in the kidney
35. Renal and systemic nitric oxide synthesis in rats with renal mass reduction
36. Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production
37. Renal disease: The two faces of nitric oxide
38. Potential physiologic roles for epidermal growth factor in the kidney
39. Expression of connective tissue growth factor in human renal fibrosis
40. Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney
41. Cell-cell cross-talk in the pathogenesis of renal interstitial fibrosis
42. Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats
43. Vascular endothelial growth factor and diabetes: The agonist versus antagonist paradox
44. Expression of vascular endothelial growth factor in renal vascular disease and renal allografts
45. Role of vascular endothelial growth factor in the regulation of angiogenesis
46. Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells
47. Vascular endothelial growth factor expression in human chronic renal allograft rejection
48. Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases
49. Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation
50. Increased expression of heparin binding epidermal growth-factor-like growth factor mRNA in the kidney of streptozotocin-induced diabetic rats
51. High glucose and hyperosmolality stimulate hepatocyte growth factor secretion from cultured human mesangial cells
52. Increased kidney and liver insulin-like growth factor II/mannose-6-phosphate receptor concentration in experimental diabetes in rats
53. Mechanisms of tubulo-interstitial injury in progressive renal diseases
54. Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions: Evidence for a role for insulin-like growth factor I
55. Proteinuria and tubulointerstitial injury
56. Remnant kidney hypermetabolism and progression of chronic renal failure
57. Physiological changes in extracellular sodium directly control human proximal tubule cell growth and transport
58. Pexicrine effects of basement membrane components on membrane signalling by renal tubular cells
59. Human renal fibroblasts regulate proximal tubule cell growth and transport via the IGF-1 axis
60. Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells
61. Crinopexy: Extracellular regulation of growth factor action
62. Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial proliferation and differentiation
63. Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system
64. Manidipine regulates the transcription of cytokine genes
65. The effect of lipid reduction on renal failure progression: A meta-analysis
66. Molecular therapy for renal diseases
67. Subtotal nephrectomy: A mosaic of growth factors
68. Roles of insulinlike growth factor I (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells
69. Tyrphostins: Tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction
70. Therapeutic uses of microencapsulated genetically engineered cells